Intense ADT Prior to RP May Improve Outcomes in Locally Advanced PCa
A phase 2 study demonstrated higher rates of pathologic complete response or minimal residual disease.
PROSTATE CANCER ADVISOR
Prostate Cancer
Features
-
-
Online Calculator May Aid In Individualizing Prostate Cancer Care
Researchers at the University of Michigan in Ann Arbor have proposed an online calculator to aid patients with localized prostate cancer (PCa) in deciding whether surgery or radiation therapy is their best treatment option, a question that randomized trials have not fully addressed. “Helping guide men with localized prostate cancer through their initial treatment decision… -
Early Post-RP Complications Directly Related to Age
The risk of virtually all early postoperative complications increases with increasing patient age at radical prostatectomy for localized prostate cancer. -
PCa Phenotype May Predict Response to Immune Checkpoint Blockade
The MSI-H/dMMR phenotype in men with advanced PCa is associated with greater likelihood of a durable response to PD-1/PD-L1 inhibitors.
Latest Prostate Cancer News
Prostate Cancer ADT Found to Increase Depression Risk
Men who receive androgen deprivation therapy after radical prostatectomy have a nearly 2-fold increased risk of depression compared with those who receive no post-surgical treatment.
Long-Term PCa Treatment Outcomes Superior With Radiation Plus ADT
Updated findings from a phase 3 study show significantly better 8-year progression-free survival with external beam radiation therapy added to androgen deprivation therapy (ADT) vs ADT alone.
Prostate mpMRI May Be Helpful in the Neoadjuvant PCa Therapy Setting
Prostate mpMRI findings before and after neoadjuvant therapy prior to robotic prostatectomy could be useful in assessing whether high-risk patients are suitable surgical candidates.
Morbidity Low With Focal Laser Ablation of Prostate Cancer
Tumor diameter above the median was only significant predictor for positive MRI after treatment
Agent Orange Possibly Protective in Prostate Cancer ADT Recipients
New study finds that Vietnam War exposure to the defoliant Agent Orange is associated with a reduced death risk among men receiving androgen deprivation therapy for advanced prostate cancer.
Biparametric MRI May Suffice for Prostate Cancer Detection
Biparametric MRI detects prostate tumors with an accuracy similar to that of multiparametric MRI without the cost and risks associated with intravenous gadolinium contrast, a new meta-analysis suggests.
Investigating CD133 as a Biomarker of Prostate Cancer Disparity in African American Men
CD133 has often been used as a marker of cancer stem cells.
Prostate Cancer Incidence Dropping, Stable in Most Countries
Decreases in mortality seen in 14 countries, stabilization in 54 of 71 countries
Adjuvant Docetaxel Possibly Beneficial in High-Risk Prostate Cancer
In a study, adding docetaxel to androgen deprivation and radiation therapy for selected men with high-risk localized prostate cancer improved overall and metastasis-free survival.
Docetaxel Chemo Ups Survival in High-Risk Localized Prostate Cancer
Findings based on addition of docetaxel chemotherapy to androgen suppression, radiotherapy
Want to read more?
Please login or register first to view this content.
Next post in Prostate Cancer
